AU2003264030A1 - Improved method to identify targeting molecules - Google Patents

Improved method to identify targeting molecules

Info

Publication number: AU2003264030A1
Authority: AU; Australia
Prior art keywords: improved method; targeting molecules; identify targeting; identify; molecules
Prior art date: 2002-08-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003264030A

Other versions

AU2003264030A8 (en

Inventor

Xiao- Min Fan

Elias Lazarides

Catherine Mary Woods

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Targeted Molecules Corp

Original Assignee

Targeted Molecules Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-08

Filing date

2003-08-08

Publication date

2004-02-25

2003-08-08 Application filed by Targeted Molecules Corp filed Critical Targeted Molecules Corp

2004-02-25 Publication of AU2003264030A8 publication Critical patent/AU2003264030A8/en

2004-02-25 Publication of AU2003264030A1 publication Critical patent/AU2003264030A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Biophysics (AREA)
Cell Biology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Hematology (AREA)
Genetics & Genomics (AREA)
Pathology (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Tropical Medicine & Parasitology (AREA)
Biotechnology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2003264030A 2002-08-08 2003-08-08 Improved method to identify targeting molecules Abandoned AU2003264030A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US40237202P	2002-08-08	2002-08-08
US60/402,372		2002-08-08
US74092703P	2003-05-14	2003-05-14
US60/740,927		2003-05-14
PCT/US2003/024994 WO2004015392A2 (en)	2002-08-08	2003-08-08	Improved method to identify targeting molecules

Publications (2)

Publication Number	Publication Date
AU2003264030A8 AU2003264030A8 (en)	2004-02-25
AU2003264030A1 true AU2003264030A1 (en)	2004-02-25

Family

ID=31720595

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003264030A Abandoned AU2003264030A1 (en)	2002-08-08	2003-08-08	Improved method to identify targeting molecules

Country Status (4)

Country	Link
EP (1)	EP1542733A2 (en)
AU (1)	AU2003264030A1 (en)
CA (1)	CA2494551A1 (en)
WO (1)	WO2004015392A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2534899A1 (en) *	2003-08-08	2005-02-17	Tissue Targeting Japan Inc.	Polypeptides having brain-localizing activity and uses thereof
WO2007023930A1 (en) *	2005-08-26	2007-03-01	Tissue Targeting Japan Inc.	Brain-migrating cell and use thereof
FR2957597A1 (en) *	2010-03-17	2011-09-23	Univ Picardie	SYNTHETIC CYCLOPEPTIDES, PROCESS FOR PREPARATION AND USES
CN108484640B (en) *	2018-05-22	2020-09-15	南京华威医药科技集团有限公司	Anti-tumor apoptosis protein inhibitor
EP4577229A1 (en) *	2022-08-22	2025-07-02	University of Tartu	Brain penetrating peptides and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4684621A (en) *	1984-11-21	1987-08-04	Smithkline Beckman Corporation	Methods of producing vasodilation or antioxytocic activity
US5622699A (en) *	1995-09-11	1997-04-22	La Jolla Cancer Research Foundation	Method of identifying molecules that home to a selected organ in vivo
EP0927045B1 (en) *	1996-09-10	2005-12-14	The Burnham Institute	Tumor homing molecules, conjugates derived therefrom, and methods of using same

2003
- 2003-08-08 AU AU2003264030A patent/AU2003264030A1/en not_active Abandoned
- 2003-08-08 EP EP03785119A patent/EP1542733A2/en not_active Ceased
- 2003-08-08 CA CA002494551A patent/CA2494551A1/en not_active Abandoned
- 2003-08-08 WO PCT/US2003/024994 patent/WO2004015392A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2004015392A2 (en)	2004-02-19
EP1542733A2 (en)	2005-06-22
AU2003264030A8 (en)	2004-02-25
CA2494551A1 (en)	2004-02-19
WO2004015392A3 (en)	2004-07-29

Publication	Publication Date	Title
AU2002329877A1 (en)	2003-12-02	Cross reference to related art
AU2003288304A1 (en)	2004-04-30	Novel molecules derived from noraporphine
AU2003237686A1 (en)	2003-12-12	Rna interference mediating small rna molecules
EP1585970A3 (en)	2005-09-01	Methods for separating molecules
AU2003903909A0 (en)	2003-08-07	Production methods
AU2003288210A1 (en)	2004-06-30	Process meter
AU2003209038A1 (en)	2003-09-09	Method to optimize information downloading
AU2003275254A1 (en)	2004-04-19	Targeted cd1d molecules
AU2003901196A0 (en)	2003-04-03	Analysis method
AU2003902613A0 (en)	2003-06-12	Self-surveying method
EP1572168A3 (en)	2005-09-22	Anti-infarction molecules
AUPS239302A0 (en)	2002-06-13	Improvements to tow-bars
AU2003264030A1 (en)	2004-02-25	Improved method to identify targeting molecules
AU2003201559A1 (en)	2003-07-24	Multispecific binding molecules
AU2003255804A1 (en)	2004-03-29	Comparison of molecules using field points
AU2003223295A1 (en)	2003-10-08	Process and intermediates to substituted imidazopyrimidines
AU2003212825A1 (en)	2003-09-02	Aggrecanase molecules
AU2003290332A1 (en)	2005-07-21	Identification of single molecules
AU2003243143A1 (en)	2004-11-19	2-methyl-thieno-benzodiazepine process
AU2003240683A1 (en)	2003-12-12	Method for creating polynucleotide molecules
AU2003276655A1 (en)	2004-05-25	Pi - conjugated molecules
AU2003230760A1 (en)	2003-10-13	Lipid-associated molecules
AU2003273258A1 (en)	2004-03-19	Process to prepare psorospermin
AU2003903723A0 (en)	2003-07-31	Process
AU2003283943A1 (en)	2005-06-08	Method

Legal Events

Date	Code	Title	Description
2005-06-09	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase